Press Releases
Press Releases
Celltrion’s regdanvimab becomes the first authorized COVID-19 treatment approved from the Korean MFDS
Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19 for the extended use in elderly patients aged 50 years and over, or with at least one...
Clinical Trials
RedHill Biopharma Reports Top-Line Data from Opaganib Phase 2/3 Study in Severe COVID-19 Patients
RedHill Biopharma Ltd. , a specialty biopharmaceutical company, announced preliminary top-line data from the 475-patient global Phase 2/3 study with opaganib (ABC294640) in hospitalized patients with severe COVID-19 pneumonia.
Preliminary top-line data showed that the study did not meet its...
Drug Research
Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance
Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum Institute of India Pvt. Ltd. announced a strategic alliance.
Under the terms of the agreement, BBL will offer approximately...
Press Releases
Pharmapack Europe: Innovation, Networking and Education
Welcome to Pharmapack Europe 2021!
It is an extremely exciting time for the pharmaceutical drug delivery and packaging industry as we emerge from the pandemic driven forward by renewed emphasis on innovation, sustainable supply chains & speeding products to market....
Packaging & Labelling
FedEx Delivers Critical COVID-19 Aid to Indonesia
FedEx Express, a subsidiary of FedEx Corp., and one of the worldโs largest express transportation companies, delivered a shipment of 15 pallets carrying COVID-19 swab kits and personal protective equipment to Jakarta, Indonesia.
The critical relief aid arrived in Jakarta...
Press Releases
Emergent BioSolutions Manufacturing Agreement with Providence Therapeutics for its mRNA COVID-19 Vaccine Candidate
Emergent BioSolutions Inc. and Providence Therapeutics announced they have entered into a five-year contract development and manufacturing (CDMO) services agreement spanning Emergentโs integrated capabilities, including development services, bulk drug substance formulation and drug product manufacturing, to support Providenceโs COVID-19...
IT & Data Management
IBM Research and Arctoris accelerate closed loop drug discovery with AI and Cloud
IBM Research and Arctoris announced they are investigating the application of AI and automation to accelerate closed loop molecule discovery. IBM Research has developed RXN for Chemistry, an online platform leveraging state-of-the-art Natural Language Processing (NLP) architectures to automate...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















